RODMAN & RENSHAW INVESTMENT CONFERENCE, NEW YORK
Meet the future of antibody-based immuno-oncology drugs.
CEO Per Norlén is presenting the company at the 20th Annual Rodman & Renshaw Global Investment Conference in New York on September 6, at 3.25 pm EDT (9:25 pm CEST).
The presentation can be followed live and afterwards at http://wsw.com/webcast/rrshq28/atorx/.
Alligator Bioscience Capital Markets Day in Stockholm on May 29, 2018
Frontier
A magazine about Alligator Bioscience and immuno-oncology
